How moves towards universal health coverage could encourage poor quality drugs: an essay by Elizabeth Pisani.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31484643.
- Also identified by DOI 10.1136/bmj.l5327 and PMC identifier 6728958.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Universal health coverage depends on affordable medicines. But pushing down prices without also investing in quality assurance will increase the sale of substandard and falsified drugs, warns <b>Elizabeth Pisani</b>